Solitek - Solid Technologies

Solitek Pharma is a Barcelona-based preclinical Contract Development and Manufacturing Organization (CDMO) specializing in solid-state science and active pharmaceutical ingredient (API) development. The company provides a suite of specialized services including solid form screening, crystallization process development, computational solid-state analysis, and enabling formulation design, aimed at de-risking and accelerating early-stage drug development for its clients. With a team boasting decades of experience and a track record of over 1,000 projects, Solitek positions itself as a strategic partner to help clients avoid costly solid-form failures and navigate complex Chemistry, Manufacturing, and Controls (CMC) challenges. Its business model is entirely service-based, catering to the outsourced needs of the broader pharmaceutical industry.

Integrated suite of proprietary methodologies and scientific know-how in solid-state API development, including computational solid-state analysis, solid form screening, crystallization process development, and advanced physicochemical characterization.

Solitek competes in the preclinical CRO/CDMO space, facing competition from global giants like Lonza and Catalent with full-service offerings, as well as numerous specialized firms focusing on crystallography, polymorphism, and pre-formulation. Its differentiation hinges on deep, focused expertise in solid-state science and a client-partner consulting model.